Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
respiratory save search
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Published: 2024-04-25 (Crawled : 12:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 23K
|
Health Technology
|
| O: -3.3%
H: 0.0%
C: 0.0%
congress respiratory cytomegalovirus research global
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 19:00) - biospace.com/
PGEN | $1.42 1.43% 1.41% 0
|
Health Technology
|
| O: 0.0%
H: 2.14%
C: 1.43%
prgn-2012 respiratory asco treatment immunotherapy for meeting study
Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
Published: 2024-04-03 (Crawled : 13:00) - globenewswire.com
SRZN | $8.97 4
|
|
| O: 4.86%
H: 8.33%
C: 8.16%
antibody fibrosis promise study
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th
Published: 2024-03-28 (Crawled : 20:00) - prnewswire.com
PGEN | $1.42 1.43% 1.41% 0
|
Health Technology
| Email alert
Add to watchlist
day respiratory international foundation
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
Published: 2024-03-27 (Crawled : 20:00) - prnewswire.com
INSM | $25.81 2.14% 1.98% 0
|
Health Technology
|
| O: -0.37%
H: 1.21%
C: -0.33%
conference respiratory international
Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis
Published: 2024-03-12 (Crawled : 20:00) - prnewswire.com
PGEN | $1.42 1.43% 1.41% 0
|
Health Technology
|
| O: 0.33%
H: 3.97%
C: 0.66%
prgn-2012 respiratory treatment immunotherapy
Global Respiratory Care Devices Research Report 2024: A $38.75+ Billion Market by 2030, Driven by Rising Demand in Home Care Settings, Rising Incidence of Allergies, and Sleep Apnea Epidemic
Published: 2024-03-12 (Crawled : 00:00) - prnewswire.com
RMD | $183.78 -0.24% 0.0% 0
|
Health Technology
|
| O: -0.26%
H: 2.88%
C: 2.39%
MDT | $80.38 -1.12% -0.03% 0
|
Health Technology
|
| O: -0.41%
H: 1.1%
C: 0.69%
GE | News | $158.06 -0.71% 530K
|
Electronic Technology
|
| O: 0.53%
H: 0.21%
C: 0.01%
MASI | $135.92 -0.75% -0.75% 0
|
Health Technology
|
| O: -0.48%
H: 0.88%
C: 0.31%
report respiratory care research global home market
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
Published: 2024-03-11 (Crawled : 19:00) - prnewswire.com
INVVY | $21.8455 19.02% 8.1K
|
n/a
| Email alert
Add to watchlist
opvee respiratory depression publication spray study
ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific Advisors
Published: 2024-03-06 (Crawled : 12:00) - globenewswire.com
ASLN | News | $0.47 0.21% 3.56% 2.1K
|
Health Technology
|
| O: 5.06%
H: 21.42%
C: 9.49%
respiratory pharmaceuticals copd
Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published: 2024-03-05 (Crawled : 05:00) - prnewswire.com
TMO | News | $577.39 0.49% 430
|
Health Technology
|
| O: -0.09%
H: 0.86%
C: 0.6%
DGX | News | $137.42 -0.1% 33K
|
Health Services
|
| O: 0.38%
H: 0.69%
C: -1.01%
NVS | News | $98.35 1.1% 0.32% 5.9K
|
Health Technology
|
| O: 0.32%
H: 0.22%
C: -0.2%
BIO | $278.21 -2.48% 0.0% 1
|
Health Technology
|
| O: -0.53%
H: 1.08%
C: -0.59%
ABT | News | $106.76 -0.12% 150K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: 0.0%
QDEL | News 4 | $40.82 1.04% 1.0% 0
|
Health Technology
|
| O: 0.18%
H: 1.13%
C: -3.31%
report respiratory global rsv virus diagnostics growth market
MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications
Published: 2024-02-06 (Crawled : 13:00) - globenewswire.com
INKT | $0.889 2.07% 0.11% 120
|
|
| O: 5.56%
H: 5.56%
C: 4.44%
respiratory treatment communications results
Global Respiratory Drug Delivery Market Report 2024 - A US$67 Billion Market - Trends in Metered Dose Inhaler (MDI) Technology to Propel the Market
Published: 2024-01-31 (Crawled : 17:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.32% 5.9K
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
PHG | News | $20.97 -0.19% -1.05% 0
|
Health Technology
|
| O: -0.09%
H: 0.93%
C: -1.31%
drug propel report respiratory global trends technology market
Trupanion Reconvenes Council on Animal Health to Provide Update on ‘Mystery’ Canine Respiratory Illness
Published: 2024-01-30 (Crawled : 17:00) - globenewswire.com
TRUP | $23.91 14K
|
Finance
|
| O: -1.5%
H: 1.1%
C: 1.02%
health respiratory animal update
Global Respiratory Disease Vaccine Market Set for Growth, Fueled by Aging Populations and Vaccine Mandates - Trends, Opportunities, and Forecasts, 2018-2028F
Published: 2024-01-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: -0.15%
AZNCF | News | $135.35 -3.53% -4.19% 0
|
Health Technology
|
| O: 2.63%
H: 0.8%
C: 0.75%
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: 1.8%
H: 0.14%
C: -0.89%
disease vaccine respiratory global set market
INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
Published: 2024-01-22 (Crawled : 14:30) - biospace.com/
INO | $10.16 -2.03% -2.67% 17
|
Health Technology
|
| O: 0.82%
H: 5.87%
C: 1.74%
respiratory treatment key potential
Global Respiratory Diagnostics Market to Reach $8.2 Billion by 2029 - A Deep Dive into Products, Regions, and Emerging Economies
Published: 2024-01-19 (Crawled : 03:00) - prnewswire.com
TMO | News | $577.39 0.49% 430
|
Health Technology
|
| O: 1.46%
H: 0.0%
C: 0.0%
ABT | News | $106.76 -0.12% 150K
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
MASI | $135.92 -0.75% -0.75% 0
|
Health Technology
|
| O: 0.21%
H: 2.21%
C: 1.9%
respiratory reach global diagnostics market
Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
Published: 2024-01-16 (Crawled : 13:00) - prnewswire.com
PGEN | $1.42 1.43% 1.41% 0
|
Health Technology
|
| O: 2.92%
H: 0.0%
C: -7.45%
prgn-2012 drug respiratory treatment designation
Global Respiratory Diagnostics Industry Forecast 2024-2033 Featuring Analysis of Philips Healthcare, BD & Company, Thermo Fisher Scientific, and Abbott Labs Among Other Key Players
Published: 2023-12-22 (Crawled : 18:00) - prnewswire.com
BIO | $278.21 -2.48% 0.0% 1
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $577.39 0.49% 430
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $106.76 -0.12% 150K
|
Health Technology
| Email alert
Add to watchlist
respiratory global diagnostics
Thermo Fisher Scientific’s PPD Clinical Research Business Selected by BARDA to Support Phase II Platform Clinical Trial to Treat Acute Respiratory Distress Syndrome (ARDS)
Published: 2023-12-21 (Crawled : 15:00) - biospace.com/
TMO | News | $577.39 0.49% 430
|
Health Technology
|
| O: -0.26%
H: 1.73%
C: 1.64%
business respiratory treat research trial platform
Thermo Fisher Scientific Introduces New Sample Preparation Solutions to Simplify and Automate Respiratory Diagnostic Testing
Published: 2023-12-11 (Crawled : 14:00) - biospace.com/
TMO | News | $577.39 0.49% 430
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
diagnostic respiratory solutions
Gainers vs Losers
| 50% | 50% |
Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M
|
Consumer Services
BRFH 4 | $1.99 80.91% 13M
|
Manufacturing
BOF | $1.915 63.68% 620K
|
ACON | $0.3595 24.83% 3.5M
|
n/a
CDTX | News | $14.57 18.55% 330K
|
Health Technology
ULBI M | $10.12 15.92% 120K
|
Producer Manufacturing
LRHC | $1.79 11.88% 3K
|
n/a
TRU | $74.475 8.44% 100K
|
Technology Services
BQ | $0.279 7.31% 14K
|
Consumer Non-Durables
CASI | $2.61 6.97% 13K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.